Life sciences employer

Azurity Pharmaceuticals

60+ open positions

What Azurity Pharmaceuticals is hiring for

60+ active

Claim to unlock

Mission, culture, and benefits - visible once this page is claimed and verified.

Azurity Announces Plans to Commercialize D-PLEX100 in the U.S. and Canada through Exclusive Partnership with PolyPid

Azurity Pharmaceuticals Expands Portfolio with CONTRAVE® and Related Assets

Azurity Pharmaceuticals Announces FDA Approval of Aprepitant Injectable Emulsion, Expanding Access to Critical Supportive Oncology Care

ACA Pharma and Azurity Pharmaceuticals Announce Approval of Feraheme® and Ferabright™ in Macau

Azurity Pharmaceuticals Announces the Availability of ARYNTATM (lisdexamfetamine dimesylate) Oral Solution, CII

Azurity Pharmaceuticals Announces FerabrightTM (ferumoxytol injection) Now Available in the U.S. for Magnetic Resonance Imaging of the Brain